GO/TiO<sub>2</sub> Hybrid Nanoparticles as New Photosensitizers in Photodynamic Therapy of A375 Melanoma Cancer Cells

AuthorAtieh Karbalaeien
AuthorZahra Mohammadalipouren
AuthorMarveh Rahmatien
AuthorAlireza Khataeeen
AuthorMohammad Amin Moosavien
Issued Date2017-03-31en
AbstractPhotodynamic therapy (PDT) by nanoparticles (NPs) has been proposed as a new emerging therapeutic approach for the treatment of melanoma. In this study, the researchers investigate potential of photodynamic graphene oxide (GO)/TiO2 hybrid (GOT) NPs as new photosensitizers (PSs) in A375 melanoma cancer cell line. The results showed that while different concentrations of GOT NPs (1 - 100 μg/mL) were inert, their irradiation with visible-light induced growth arrest and cell death in A375 cells in a dose-despondent manner. These anti-cancer effects were accompanied by significant morphological changes, suggesting GOT NPs have a potential for further evaluation as new generation of PSs for cancer therapy.en
DOIhttps://doi.org/10.5812/jssc.63984en
KeywordA375 Cellsen
KeywordGraphene Oxide/Titanium Dioxideen
KeywordMelanomaen
KeywordPhotodynamic Therapyen
PublisherBrieflandsen
TitleGO/TiO<sub>2</sub> Hybrid Nanoparticles as New Photosensitizers in Photodynamic Therapy of A375 Melanoma Cancer Cellsen
TypeResearch Articleen

Files